ASGT 10th Annual Meeting
May 30 - June 3, 2007
Washington State Convention & Trade Center · Seattle, WA · USA
|
|
|
ASGT 10th Annual Meeting May 30 - June 3, 2007 Washington State Convention & Trade Center · Seattle, WA · USA |
||
|
||
ASGT 10th Annual Meeting
|
|||||||||||||||||||||||||||||||||||||||||
| Wednesday, May 30 |
|
Early-Bird Session 12:30 pm – 3:30 pm Bioprocessing Symposium: Novel Technologies in the Manufacturing and Analysis of Gene Transfer Agents Chair Ralph W. Paul, PhD Speakers Vijay Singh, PhD Bioreactors for Gene and Cell Therapy Applications |
|
Alain Rolland, PharmD, PhD Analysis of Plasmid-Based Products: Development of a Novel Potency Assay |
|
Marcela Maus, MD, PhD Clinical Prospects for Genetically Engineered Artificial Antigen Presenting Cells |
|
Maritza C. McIntyre, PhD Process Development for Gene Therapy Products: Who, What, When, Where and How? |
|
Daniel R. Hollyman, PhD Scaled-Up Manufacturing of Genetically Modified T Lymphocytes for Phase I/II Clinical Trials |
|
Menzo Havenga, PhD The PER.C6 Cell Platform for Gene Therapy and Vaccine Products |
|
Early-Bird Session 12:30 pm – 3:30 pm International Symposium: Gene Therapy Clinical Trials from Around the Globe Chair Jesus Prieto, MD, PhD Speakers Ryuichi Morishita, MD, PhD Favorable Results of Clinical Trials of HGF (Hepatocyte Growth Factor) Gene Therapy in Peripheral Artery Disease |
|
Vivien Mautner, PhD Suicide Gene Therapy using an Adenovirus Expressing Nitroreductase with the Prodrug CB1954: A Phase I/II Clinical Trail for Prostate Cancer |
|
Masafumi Onodera, MD, PhD Gene Therapy for Hematologic Malignancy |
|
Bruno Sangro, MD, PhD Gene Therapy of Liver Cancer using Adenoviral Vectors |
|
Tadashi Ariga, MD, PhD Hematopoietic Stem Cell (HSC) Gene Therapy for Two Patients with Adenosine Deaminase (ADA) without Myelopreparative Conditioning: A Suggestion for the Optimal Protocol for HSC Gene Therapy for ADA Deficiency |
|
Erik S.G. Stroes, MD, PhD Efficacy and Safety of Intramuscular Administration of AMT-010 (AAV-LPLS447X) in Lipoprotein Lipase Deficient Subjects |
| Special Symposium 4:00 pm - 7:15 pm Enhancing the Science, Safety and Ethics of Human Gene Transfer Research: The NIH System of Review and Oversight Chair Amy Patterson, MD Speakers TBD |
|
Education Sessions The goal of the ASGT Education Program is to provide participants with a broad background and introduction to topics relevant to the field of gene therapy. Education Sessions will be subdivided into two headings. “Topical Review” sessions will provide a broad perspective of an area of importance to the gene therapy community such as major vector systems, specific target organs or diseases, and funding/regulatory issues. “Emerging Field Review” sessions will provide a broad perspective of a technological or scientific discipline that has recently become of great significance to our members. |
|
Education Session 100 4:00 pm – 5:30 pm Emerging Field Review: Innate Immunity and Regulation of the Immune System Chair Roland W. Herzog, PhD Speakers Alan Aderem, PhD Christopher B. Wilson, MD Alexander Y. Rudensky, PhD |
|
Education Session 101 4:00 pm – 5:30 pm Emerging Field Review: In Vivo Imaging Chair Philip L. Leopold, PhD Speakers R. Scott McIvor, PhD Thomas K. Lewellen, PhD William Goins, PhD |
|
Education Session 102 4:00 pm – 5:30 pm Topical Review: Non-viral Vector Design and Efficacy Chair Dexi Liu, PhD Speakers Michele P. Calos, PhD Hideyoshi Harashima, PhD Ian MacLachlan, PhD |
|
Education Session 103 4:00 pm – 5:30 pm Topical Review: Retroviruses, Lentiviruses and Therapy for Hematologic Disease Chair Donald B. Kohn, MD Speakers Fabio Candotti, MD Tim Townes, PhD Katherine Ponder, MD |
|
Education Session 104 4:00 pm – 5:30 pm Topical Review: Cancer Therapy Chair Terry Hermiston, PhD Speakers David H. Kirn, MD Jonathan W. Simons, MD Steve H. Thorne, PhD |
|
Break 5:30 pm – 5:45 pm |
|
Education Session 110 5:45 pm – 7:15 pm Emerging Field Review: Strategies for Stem Cell Therapies Chair Fulvio Mavilio, PhD, Prof Speakers Evan Snyder, MD, PhD Charles Murry, PhD Nick Giannoukakis, PhD |
|
Education Session 111 5:45 pm – 7:15 pm Emerging Field Review: Regulatory RNAs Chair Paul B. McCray, Jr., MD Speakers Paloma H. Giangrande, PhD Paul B. McCray, Jr., MD |
|
Education Session 112 5:45 pm – 7:15 pm Topical Review: AAV Vectors and Therapies for Monogenic Disorders Chair Dongsheng Duan, PhD Speakers Joseph Rabinowitz, PhD Jeffrey Chamberlain, PhD Dongsheng Duan, PhD |
|
Education Session 113 5:45 pm – 7:15 pm Topical Review: Viral Vectors and Vaccines for Infectious Diseases Chair Roberto Cattaneo, PhD Speakers Michael A. Barry, PhD Roberto Cattaneo, PhD Bernard Moss, MD, PhD |
|
Exhibit Hall Social and Exhibits (Exhibits open at 5:00 pm) 7:00 pm – 9:00 pm |
© 2001-2007 All rights reserved. American Society of Gene Therapy